Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its Effect on the Neutralizing Activity of Monoclonal Antibodies, Convalescent Antibodies and Vaccine-Elicited Antibodies
14 déc. 2021 16h40 HE
|
Vir Biotechnology, Inc.
– Data demonstrate sotrovimab, developed by Vir in conjunction with GlaxoSmithKline, continues to retain in vitro neutralizing activity against all tested variants of concern, including Omicron – SAN...
Aalto Bio Reagents announces SARS nCOV 2 NP and Mabs for Omicron Variant
13 déc. 2021 09h00 HE
|
Aalto Bio Reagents Ltd
DUBLIN, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Aalto Bio Reagents ltd., a leading developer of critical raw materials and reagents for the development of diagnostic tests globally, announced today that...
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders
13 déc. 2021 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Dec. 13, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma Names Brian Feagan, M.D., to Scientific Advisory Board
09 déc. 2021 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Dec. 09, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Persbericht Biocartis Group NV: Biocartis’ Idylla™ SARS-CoV-2 testing detecteert met succes de omicron variant
09 déc. 2021 01h00 HE
|
Biocartis NV
PERSBERICHT: 9 december 2021, 07:00 CET Biocartis’ Idylla™ SARS-CoV-2 testing detecteert met succes de omicron variant Mechelen, België, 9 december 2021 – Biocartis Group NV (de ‘Vennootschap’...
Press release Biocartis Group NV: Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant
09 déc. 2021 01h00 HE
|
Biocartis NV
PRESS RELEASE: 9 December 2021, 07:00 CET Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant Mechelen, Belgium, 9 December 2021 – Biocartis Group NV (the ‘Company’ or...
Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Full Product Registration Approval in Indonesia
08 déc. 2021 07h50 HE
|
Achiko AG
Second-generation of AptameX, Achiko’s innovative DNA aptamer diagnostic test for Covid-19 has received full approval in Indonesia for five yearsProduction of the second-generation AptameX kits to...
BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant
08 déc. 2021 07h15 HE
|
BioNTech SE
MAINZ, Germany, December 8, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will hold a digital press conference on Wednesday, December 8, 2021, to present the results from initial...
BioNTech gibt virtuelle Pressekonferenz zu Omikron-Variante
08 déc. 2021 07h15 HE
|
BioNTech SE
MAINZ, Deutschland, 8. Dezember 2021 – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Mittwoch, den 8. Dezember 2021, eine virtuelle Pressekonferenz abhalten, um die Ergebnisse...
Pfizer and BioNTech Provide Update on Omicron Variant
08 déc. 2021 06h56 HE
|
BioNTech SE
Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage), while two doses show significantly reduced...